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Abstract 
Innovative engineered nanomaterials are at the leading edge of rapidly emerging fields of nanobiotechnology and 
nanomedicine. Meticulous synthesis, unique physicochemical properties, manifestation of chemical or biological 
moieties on the surface of materials make engineered nanostructures suitable for a variety of biomedical applications. 
Besides, tailored nanomaterials exhibit entirely novel therapeutic applications with better functionality, sensitivity, 
efficiency and specificity due to their customized unique physicochemical and surface properties. Additionally, such 
designer made nanomaterials has potential to generate series of interactions with various biological entities includ-
ing DNA, proteins, membranes, cells and organelles at nano-bio interface. These nano-bio interactions are driven by 
colloidal forces and predominantly depend on the dynamic physicochemical and surface properties of nanomaterials. 
Nevertheless, recent development and atomic scale tailoring of various physical, chemical and surface properties of 
nanomaterials is promising to dictate their interaction in anticipated manner with biological entities for biomedical 
applications. As a result, rationally designed nanomaterials are in extensive demand for bio-molecular detection and 
diagnostics, therapeutics, drug and gene delivery, fluorescent labelling, tissue engineering, biochemical sensing and 
other pharmaceuticals applications. However, toxicity and risk associated with engineered nanomaterials is rather 
unclear or not well understood; which is gaining considerable attention and the field of nanotoxicology is evolving 
promptly. Therefore, this review explores current knowledge of articulate engineering of nanomaterials for biomedical 
applications with special attention on potential toxicological perspectives.
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1 Introduction
Nanostructures are engineered assemblies of materi-
als with at least one dimension equivalent to 100 nm or 
less as defined by the National Nanotechnology Initia-
tive (NNI). These nano scale materials are significantly 
important and increasingly being employed for com-
mercial purposes in various sectors, wherein some of 
the advanced nanomaterials are at the leading edge of 
nascent fields of nanobiotechnology and nanomedicine 
[1–6]. Material at nano scale range exhibit unique physic-
ochemical properties, which are accredited to their ultra-
small size, high surface to volume ratio, composition, 
presence of biochemical moieties on surface (peripheral 
coatings or functional groups), hydrophilic or hydropho-
bic nature, physical appearance (shape or morphology) 
and aggregation [7] as illustrated in Fig. 1.
Due to the above stated unusual physicochemical 
belongings, nanomaterials differ considerably from the 
bulk material of the alike composition, permitting them 
to execute remarkable feats of better functionality, sen-
sitivity, efficiency and specificity in terms of their thera-
peutic or biomedical applications [1, 8, 9]. Furthermore, 
contemporary progress in the field of nanotechnology 
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has given ability to rationally design a variety of nano-
materials and manipulate their chemical, physical and 
potential biological properties for drug screening (label-
ling), gene delivery (transfection), diagnosis/monitoring 
(devices and labelling), drug delivery (therapy), detection 
(imaging), tissue engineering and other biomedical appli-
cations. It is apparent that the nanomedicine is equiva-
lent to traditional medicine but with better prospects to 
diagnose precisely and promptly, to cure diseases effi-
ciently without or minimal side effects. For example, by 
manipulating therapeutic agents and other materials at 
the nanoscale level, their essential properties and bioac-
tivity can be transformed. Such transformed characteris-
tics can permit control over therapeutic agents/drugs in 
terms of their solubility, blood pool retention times, con-
trolled release over short or long durations, environmen-
tally triggered controlled release or definite site-targeted 
delivery [1, 4, 5, 8, 10–22].
In the context of nanomedicine, a variety of materials 
have been utilized for their potential medical applica-
tions, wherein metallic nanoparticles have been proven 
the most convenient and suitable due to their unique 
optical, physical and electrical properties. These materi-
als have found noteworthy applications in imaging, sens-
ing, drug delivery and gene targeting. Numerous studies 
related to metallic particles such as gold and silver nano-
particles have been discussed in different sections of this 
review in terms of their application and toxicity [18, 23–
31]. In addition to metallic nanoparticles, carbon based 
materials such as fullerenes, nanotubes, nanodiamonds 
and graphene are important nanomaterials for biomedi-
cal applications. Fullerenes, graphene and their deriva-
tives have shown good biocompatibility which makes 
them attractive candidate for biomedical applications 
especially for bio-sensing, -imaging and drug delivery. 
Fullerenes have been regarded as a double-edged sword; 
because they display therapeutic applicability at lower 
concentrations; however, at the higher concentrations 
they induce inflammation and if chronic, may promote 
cancer. Likewise, contemporary research has indicated 
that graphene and its derivatives may cause cytotoxicity 
in experimental in vitro and in vivo conditions along with 
genotoxicity and innovative methodologies need to be 
employed to evaluate their toxicities [32]. Another car-
bon based material diamond nanoparticles have shown 
their importance as single-particle biomarker for fluores-
cence imaging. Moreover, surface of these nanoparticles 
can be effectively functionalized to bind with a variety 
of proteins and nucleic acids, empowering them to be 
employed as a carrier for pharmaceutical agents or oligo-
nucleotides [21, 33–37].
Quantum dots (QDs) have also emerged as a novel 
class of fluorescent probe for in  vivo biomolecular and 
cellular imaging due to their size-tuneable light emis-
sion, improved signal brightness, resistance toward 
photo-bleaching and simultaneous excitation of multi-
ple fluorescence colours. Moreover, current research has 
led fabrication of multifunctional nano-probes that are 
highly bright and stable under different in  vivo condi-
tions. Additionally, polymer-encapsulated QDs have been 
prepared by encapsulating luminescent QDs with amphi-
philic block copolymers and linking the polymer coating 
to tumor-targeting ligands and drug delivery function-
alities. Interestingly, these materials have been found to 
be nontoxic to the cells and such conjugated QDs have 
raised new possibilities for ultrasensitive and multiplexed 
imaging of molecular targets in living cells, animal mod-
els and possibly in humans; however, their long-term 
in  vivo toxicity and degradation need to be more care-
fully evaluated [38]. In addition to above discussion, 
Fig. 1 Schematic representation of various physicochemical properties of nanomaterials which influences their biomedical potentials
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polymeric nanomaterials have also attracted significant 
interest, which are colloidal structures and composed 
of synthetic or semisynthetic polymers. These materials 
have extensive potential for biomedical applications and 
predominantly being used for drug or gene delivery pur-
poses due to their less toxic properties. The drug moieties 
can be entrapped, encapsulated or attached to a poly-
meric matrix for biological applications. [39, 40]. In this 
context, our group has demonstrated construction of soft 
nanostructures of biocompatible tri-block copolymer 
P-123 (PEO20–PPO69–PEO20) [poly(ethylene oxide)–
poly(propylene oxide)–poly(ethylene oxide)] for their 
utility as a non-viral DNA delivery vector in cellular envi-
ronment using Escherichia coli DH5α as a model micro-
organism. In this research, optimum weight ratio of 1:10 
of plasmid DNA to copolymer P-123 was screened to 
achieve higher transformation efficiency. The schematic 
mechanism by which pDNA and copolymer P-123 nano-
constructs release pDNA into the bacterium has been 
illustrated in Fig.  2, wherein PEO the hydrophilic part 
of polymer complex adsorbed on the cell wall and PPO 
the hydrophobic part can insert into the cell and effi-
ciently deliver pDNA [41]. Another important material at 
nanoscale level is liposome, that contains a lipid bilayer 
membrane surrounded by an aqueous interior mimicking 
the biologic membranes for improving the efficacy and 
safe delivery of anti-cancer, anti-fungal, antibiotic drugs, 
anesthetics and anti-inflammatory drugs along with the 
delivery of gene medicines [42].
Despite of numerous potential biomedical applications, 
toxicological perspective of engineered nanomaterials 
is poorly understood or rather unclear, which is gain-
ing considerable attention in terms of nanotoxicology. 
Although, nanotoxicology is in embryonic stage of its 
development; it is a vital part of nanomedicine and dis-
cusses interactions of engineered nanomaterials with 
biological systems or environment; wherein, particular 
emphasis is given on the correlations between the phys-
icochemical and surface properties of nanomaterials with 
induction of toxic or adversarial biological responses. In 
addition to this, nanotoxicology aims to discover favour-
able physicochemical characteristics of various nanoma-
terials, which may render them more responsive toward 
inner biological environment for therapeutic benefits 
[43, 44]. Therefore, the response of active biomolecule 
with living entity should be more closely related to the 
quantity of active molecule coming into the direct con-
tact with biological object rather it’s transient initial 
distribution or administered mass concentration. In a 
typical nanotoxicity study, engineered nanomaterials 
are introduced in specialized media for biological appli-
cation and dose is described as the total particle mass/
number, surface area or volume of the particles per unit 
volume of liquid media or per unit surface area of the 
well (sedimentation surface). However, in recent past 
more consideration has been given to the mass trans-
port (sedimentation/diffusion) of particles in suspension, 
which proceeds at a rate governed by the mass transport 
properties (sedimentation/diffusion-coefficients) of the 
formed agglomerates in suspension [45–47]. Therefore, 
the requirement for precise in  vitro dosimetry remains 
foremost hindrance to the further development of 
Fig. 2 Schematic representation of plasmid DNA delivery in cellular environment by employing copolymer P-123 (PEO20–PPO69–PEO20) as delivery 
vector
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cost-effective toxicological screening methods for engi-
neered nanomaterials to realize their full potential for 
biomedical applications [48]. Therefore, a careful selec-
tion of in vitro doses for nanoparticles toxicity testing is 
imperative, which largely depend upon the effective den-
sity and diameter of formed agglomerates in suspension 
[49]. From the above discussion, it appears that there is 
contradiction between nanomedicine and nanotoxicol-
ogy in terms of application and safety. Therefore, this 
review aims to explore current knowledge of engineering 
various physicochemical characteristics of materials at 
nano scale level for biomedical applications with poten-
tial toxicological perspective.
In the context of biomedical applications of nanoma-
terials, it is vital to recognize that the concomitance of 
nanomaterials and biological entity may exert detrimen-
tal effects on biological systems [50, 51]. These adverse 
effects are created due to nano-bio interfacial interac-
tions, which are driven by a series of communications 
between nanomaterial and natural boundaries of bio-
logical entities such as DNA, proteins, membranes, cells 
and organelles. Such interactions are motivated by col-
loidal forces and depend on vibrant bio-physico-chemical 
properties of nano-bio boundary leading to form protein 
corona, particle wrapping, intracellular uptake and bio-
catalytic progressions that may be bio-compatible or 
-adverse in nature [7, 23, 52].
In terms of nanomaterials toxicity, three principles 
have been elucidated which are referred as transport 
principle, surface principle and materials principle. All 
these fundamental principles of materials toxicity need to 
be considered pragmatically for dictating specific inter-
actions between nano objects and biological systems. 
Moreover, these three basic principles provide insight 
of each nanomaterial separately for their specific phys-
icochemical property, which are imperative in creating 
adversarial biological effects [51].
Therefore, to contrive nanomaterials for biomedi-
cal applications, it is imperative to rationally engineer 
nanomaterials with controlled physicochemical prop-
erties to dictate nano-bio interface toward desired 
interactions to achieve highest level of safety with bet-
ter functionality, sensitivity, efficiency and specificity. 
Moreover, basic understanding of nano-bio interfacial 
interactions between engineered nanomaterials and 
biological objects will allow predictive relationships at 
the nano-bio interface. Such predictive interactions are 
essential for the perspective of further development of 
designing strategies and safe usage of nanomaterials 
[53–55]. From the discussion, it can be established that 
prior to utilizing nanomaterials in the field of medicine 
or biology, the effects of nanomaterials must be antici-
patable and defined, and nanomaterials must exhibit 
desired therapeutic outcomes without or negligible 
cytotoxicity.
In this perspective, a variety of nanomaterials have 
been rationally designed including engineered metallic 
nanoparticles, their alloys and oxides, super-paramag-
netic oxide crystals, quantum dots, semiconductors, 
dendrimers, polymeric micelles, liposomes, aquasomes 
(carbohydrate-ceramic nanoparticles) and polyplexes/
lipopolyplexes for their vast potential towards biomedi-
cine application from diagnostics to treatment of disease 
[1, 25, 26, 56–60]. Moreover, it is imperative to state that 
the dimensional resemblance of designer made nanoma-
terials and biomolecules (enzymes, DNA, membrane, 
proteins etc.) provides noteworthy potential to tailored 
nanomaterials to substantial influence biomedical sci-
ences by achieving desired sensitivity with improved 
bio-functionality, -efficiency and -specificity as discussed 
earlier [18, 61–63]. Furthermore, contemporary progres-
sions in meticulous synthesis, development in function-
alization strategies and tranquil atomic scale tailoring of 
physicochemical properties of nanomaterials positioning 
such materials at forefront for several biomedical appli-
cations including biomolecular detection/diagnostics, 
drug/gene delivery, fluorescent labelling, tissue engineer-
ing, biochemical sensing etc. In spite of what we have 
achieved so far, a complete understanding of how cells 
interact with well-defined nanomaterial at the molecular 
level remains poorly understood and more insight need 
to be provided. Furthermore, it is inevitable to system-
atically investigate and analyse any unwanted toxicity 
or risks associated with nanomaterials prior to make a 
final clinical translation. Therefore, the next section will 
discuss that how various physicochemical properties of 
nanomaterials can be rationally engineered to influence 
their biomedical potential to achieve desired biological 
goal without any toxicological impact.
2  Engineering physicochemical properties 
at nanoscale for biomedical applications 
with controlled nanotoxicity
Nanomaterials display exceptional physicochemical 
properties and can be exploited for various biomedical 
applications as illustrated in Fig. 3 due to their controlled 
size, high surface to volume ratio, differential shape, 
well-ordered composition, meticulous surface coatings 
or functional groups, solubility, specific hydrophilic or 
hydrophobic nature and aggregation. All these physico-
chemical parameters of nanomaterials either individually 
or cooperatively can affect the initial nano-bio interfacial 
interactions, adhesion of nanomaterials on cell mem-
brane/surface, their cellular uptake or direct penetration 
inside the cells, and lastly nanomaterials communication 
with the cellular components; which ultimately translate 
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into the bio-compatibility or -toxicity of these nanomate-
rials towards a specific biological entity leading to thera-
peutic or adversative effects [7, 52].
Moreover, different physicochemical belongings of nano-
materials have possibility to produce specific chemical 
atmosphere within the cells to encourage a pro-oxidant 
environment, initiating an imbalanced cellular energy sys-
tem reliant on redox potential, thus leading to hostile bio-
logical consequences. Such hostile biological effects may 
range from the commencement of inflammatory pathways 
through to ultimate cell death [64]. Therefore, it is impera-
tive to develop deeper insight into the physicochemical 
properties of nanomaterials and their biological aspects 
after nano-bio interactions to formulate better nanoma-
terials for future biomedical or pharmaceutical appli-
cations through nanomedicine. Likewise, the intrinsic 
physicochemical and surface properties of nanomaterials 
need to be carefully designed to accomplish specific bio-
medical applications as represented in Fig.  3 without any 
toxicological influence. The succeeding section discusses 
about various physicochemical properties of nanomaterials 
which may influences their potential biomedical/toxicolog-
ical role, therefore need to be engineered prudently.
2.1  Size, shape and composition
In the context of biomedical applications of engineered 
nanomaterials, the foremost distinctive feature is their 
size, which fall in-between individual atoms or molecules 
and corresponding bulk material. The reduced size of 
nanomaterials will not only provide an opportunity for 
increased uptake but also will build chances to interact 
with biological tissues to a greater magnitude to achieve 
desired type of selective biological action for therapeu-
tic purposes [7]. Furthermore, in the recent times, it has 
been established that particle size is particularly domi-
neering while other physicochemical parameters are 
controlled. To confirm this, systematic assessment of 
size-dependent biological profile and bio-distribution 
of three monodisperse drug-silica nano-conjugates of 
20, 50 and 200  nm have been evaluated. This evalua-
tion was performed through laboratory experiments in 
conjugation with mathematical modelling to establish 
the optimal size for the most effective antitumor drug 
delivery system. Through this study, it was revealed that 
the 50  nm sized drug-silica nanoconjugate particles 
had highest cancer tissue retention over time leading to 
deeper tissue penetration and effective internalization 
within the cancer cells along with slower clearance [65].
Additionally, nanomaterials are anticipated to cross 
biological obstacles, gaining entrance to the body and 
subsequently nano size may govern their kinetics, 
absorption, distribution, metabolism and excretion that 
would not be possible otherwise with the bulk mate-
rial of akin composition [61, 66]. Well-defined gold and 
Fig. 3 Schematic representation of physicochemical properties of nanomaterials which influences their biomedical applications; biomedical appli-
cations of nanomaterials (nanomedicine) and toxicological concerns (nanotoxicology)
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silver nanoparticles ranging within the 2–100  nm size 
and coated with antibodies have been reported to regu-
late the process of membrane receptor internalization 
leading to down regulate cellular expression level. This 
in turn alters the signalling processes and subsequently 
cellular responses, which are essential for basic cell func-
tions. Furthermore, it has been demonstrated that nan-
oparticles of 40 and 50 nm size have greater effects not 
only due to their passive interaction with biological enti-
ties or cells but also due to their active engagement in 
mediating the molecular processes that are essential for 
regulating cellular activities [67]. In another study, ferro-
magnetic nanomaterials of three different sizes (300, 150 
and 30  nm) were investigated for their intrinsic peroxi-
dase-like catalytic activity. Interestingly, these nanomate-
rials displayed different levels of activity towards studied 
substrate, wherein smaller sized ferromagnetic nanoma-
terial revealed higher catalytic activity in the order of 
30  >  150  >  300 nm; since smaller particles have greater 
surface-to-volume ratio to interact with substrates [68].
Likewise, theoretical traits propose that reduced parti-
cles size will have higher surface area, which may possi-
bly promote interactions between the nanomaterials and 
the surface of biological entities, which may influence liv-
ing organism adversely. In this perspective, size depend-
ent toxicological consequences of various nanomaterials 
have been established by employing silver nanoparticles, 
palladium nanoparticles, single-walled carbon nano-
tubes and multi-walled carbon nanotubes toward bacte-
rial cells. These studies show that smaller sized particles 
directly interact with bacterial cells leading to antagonis-
tic effects confirming size-dependent toxicity [69–71]. 
Moreover, palladium nanoparticles illustrate that even 
the fine-scale of 1  nm dissimilarities can improve their 
antibacterial potential considerably and it will depend on 
the strains of the tested bacterial species [70].
In addition to size and type of material (composi-
tion), shape or morphology of a nanomaterial is another 
important characteristic feature at nanoscale level. How-
ever, only few investigations are focusing on the bio-
medical or toxicological relationship associated with this 
parameter alone. Nevertheless, in metallic nanomateri-
als various properties including electromagnetic, optical 
and catalytic properties are strongly influenced by their 
shapes [72–75]; consequently, it is believed that along 
with size of the nanoparticles, shape of nanomaterial also 
has substantial potential to influence nano-bio interfaces. 
In addition to leading cellular uptake, size of a material 
is key element that is related with the surface area for a 
specific mass-dosage. Generally, to the overall surface 
area, contribution of shape of the nanomaterials will be 
significant. For instance, an octagonal shaped nanomate-
rial will have different surface area compare to spheres of 
the equivalent size. Since surface atoms have a tendency 
to hold unsatisfied high energy bonds, the higher cata-
lytic activity of nanomaterial with larger surface areas 
enhances its reactivity. Therefore, after effective entry 
within the cellular milieu these nanomaterials will have 
better probabilities compared to counterpart micron-
sized particles to intermingle with biomolecules of cells, 
triggering direct cellular destruction and promoting oxi-
dative stress [43, 76].
Recently, it was demonstrated that the shape of nano-
material can impressively influence their rate of uptake 
by biological systems, wherein, spherical nanoparticles 
illustrate greater uptake over nanorods. Interestingly, 
internalization of nanorods was found to be depend-
ent on their dimensions and high-aspect ratio rods were 
internalized considerably faster than low-aspect ratio 
nanorods [43]. Likewise, it has been reported that trian-
gular nano-plates of silver displays higher antimicrobial 
activity, in comparison with spherical and rod-shaped 
silver nanoparticles against Escherichia coli. Further-
more, this study proposed that nano range size and the 
existence of (111) lattice plane combine to encourage 
antibacterial potential and nanoparticles commenced 
shape-dependent interaction with bacterial cells [77].
Likewise, recently a facile approach was employed by 
utilizing zwitterionic amino acids as reducing and sta-
bilizing agents to obtain stable corona on metallic gold 
and silver nanoparticles along with different composi-
tions. Antibacterial and in  vitro peroxidase-like activi-
ties of composition controlled mono and bimetallic 
gold and silver nanoparticles confirmed and along with 
other physicochemical properties, composition of the 
nanomaterial has considerable effect on their biological 
actions. Interestingly, different antimicrobial profile was 
reported toward Gram positive and Gram negative bac-
terial strains, which was significantly influenced by the 
composition of nanomaterial [20, 78]. All these above 
discussed studies determine that nanomaterials should 
no longer be regarded as simple carriers for biomedi-
cal applications but need to be engineered for nanoscale 
delivery and therapeutic application keeping their nano-
toxicity prospects in count, which is often neglected, if 
not overlooked.
2.2  Surface/volume ratio and crystal planes
Along with size, surface to volume ratio is a significantly 
important physical property of any materials at nano 
scale level. It is imperative to recognize that number of 
surface molecules increases exponentially when the size 
of nanomaterial decreases below 100 nm; and, nanoma-
terial’s size and number of surface expressed molecules 
show inverse relationship [51, 79]. Nanomaterials size 
and surface area are important material characteristics 
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from toxicological and biomedical applications perspec-
tive. As the size of nanomaterial decreases, its surface 
area increases. Increment in the surface area will allow a 
greater population of its atoms/molecules to be displayed 
on the surface of nanomaterial rather than its inte-
rior. For example, in a 30 nm sized nanomaterial, about 
10 % of its molecules are expressed in the surface; while 
nanomaterials with 10 and 3 nm size will have 20 % and 
50  % intensification in the surface expressed molecules, 
respectively. Since, number of atoms or molecules found 
on the surface of a nanomaterial are determinant of 
materials reactivity and biological profile; this will be fun-
damental for defining the chemical and biological prop-
erty of nanomaterial [7].
Furthermore, reduction in size of material can con-
struct irregular crystal planes, which can escalate the 
total number of structural defects and may disrupt 
ordered electronic configuration of the material, giv-
ing rise to altered electronic properties. All these physi-
cal changes can establish specific surface groups that 
could function as reactive sites such as hydrophilic or 
hydrophobic, catalytically active or passive etc. depend-
ing upon the chemical composition of the material [7, 
79]. In other words, when taken together, it may be indi-
cated that the greater surface area per mass compared 
with larger-sized particles of the same chemistry renders 
materials biochemically more active. This phenomenon 
of surface to volume ratio reflects the significance of 
chemical and biological activities of a nanomaterial since 
enhanced biological potential can be positive and desir-
able in terms of their antioxidant activity, carrier capac-
ity for therapeutic purposes and penetration of cellular 
barriers (nanomedicine perspectives); or enhanced bio-
logical potential can be negative and undesirable such as 
toxicity, induction of oxidative stress or cellular dysfunc-
tion (nanotoxicology perspectives). In addition to above 
stated distinct positive and negative impacts, increased 
surface to volume ratio may have mix of both the proper-
ties at the same time [79]. Therefore, while engineering 
nanomaterials for any biomedical application point of 
view, special attention need to be paid on its surface to 
volume ratio and crystal planes, since these are predomi-
nantly responsible for various structural defects and sur-
face properties which have often been neglected compare 
to other physicochemical properties.
2.3  Aggregation, stability and protein corona
In addition to size, aggregation factor of nanomaterials 
need to be considered sensibly; however, this phenom-
enon has frequently been overlooked, if not than consid-
ered trivial for many biological and medical applications, 
which is misleading. Although numerous nanomateri-
als have been fabricated with a targeted size which may 
be ultra-small, yet these particles frequently form much 
larger colloidal aggregates. Stability of prepared nanoma-
terials against aggregation is always an essential concern 
before these nanomaterials employed for any biomedi-
cal application. Stability of synthesized nanomaterials 
depends on the pH of the medium in which the nano-
materials are dispersed and the electrolyte concentration 
in the solvent [80]. Stabilization of metal based nano-
material in the solution can be accomplished by add-
ing shielding or protecting agents which are required to 
avert agglomeration. Nanomaterials produced in solvents 
are usually unstable and incline to aggregate due to their 
higher free surface energy (result of their ultra-small size) 
[80, 81].
Nonetheless, aggregation phenomenon is suitable for 
aggregation-based immunoassays techniques. In this 
respect, metallic nanoparticles are considered the most 
relevant due to their optical properties. For instance, an 
aggregation-based simple, one step immunoassay has 
been developed by employing gold nanoparticles for anti-
protein A. This extremely sensitive and specific assay was 
established based on the aggregation property of gold 
nanoparticles that were coated with protein antigens in 
the existence of their corresponding antibodies and mon-
itored in terms of absorption change at 620 nm. Moreo-
ver, such gold nanoparticles centred aggregation assay 
is capable of analysing a variety of samples concurrently 
using microplate reader [82]. Furthermore, hybridization 
of target DNA in a cross-linking or non-cross-linking 
configuration is also possible by exploiting aggregation of 
DNA-functionalized gold nanoparticles, which opens up 
new possibilities for rapid, easy and reliable genetic diag-
nosis [83].
In addition to above conversed, it is vital to recognize 
that in an experimental set-up or physiological conditions 
many nanomaterials (especially metallic nanoparticles) 
have propensity to form agglomerate because of their 
inherent high reactive nature. Hence, when nanomateri-
als are introduced to living organism/cells in physiologi-
cal environment or biological medium; it is expected that 
nanomaterials will construct aggregates rather existing 
as individual units; subsequently, the detected biologi-
cal accomplishments will be outcome of agglomerated 
form of nanomaterial. For example, antibacterial activity 
of silver nanoparticles is size dependent, wherein smaller 
silver nanoparticles exhibit higher activity on the basis of 
equivalent silver mass content. Conversely, silver nano-
particles have inclination to aggregate in media due to 
high electrolyte content, causing loss of their antibacte-
rial effectiveness. However, complexion of silver nano-
particles with stabilizing agents by surface modification 
or surface coatings can stabilize them against aggrega-
tion, leading to retention of their antibacterial potential 
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[84]. In order to improve antibacterial prospects by regu-
lating aggregation of nanomaterials, hybrid composites 
of nano silver-silica (Ag–SiO2) and nano copper-silica 
(Cu–SiO2) were prepared, wherein silver nanoparticles or 
copper nanoparticles were uniformly distributed on the 
surface of silica nanoparticles deprived of any emblem 
of aggregation and demonstrated higher antibacte-
rial capacities due to the lack of aggregation [85, 86]. 
Aggregation property of nanomaterial can be utilised for 
immunoassays, diagnosis, biosensing, antimicrobial and 
other applications. Therefore, nanomaterials need to be 
designed rationally while utilizing aggregation phenom-
enon for biomedical applications with their potential sta-
bility and toxicity in count.
Interestingly, nanomaterials, in general will be taken-
up via endocytosis process, during which they are 
exposed to highly varying pH conditions ranging from 
7.4 (extracellular medium), 5.5 (late endosomes), to 4.5 
(lysosomes). Therefore, the chemical strength of the 
nanomaterials exposed to the disintegrative endosomal 
environment gaining increasing consideration. In this 
context, it is further imperative to notice that in addition 
to acidic pH, lysosomes possess high levels of hydrolytic 
bio-catalysis that has potential to degrade any nano-
materials completely or to their surface corona, which 
is required for particle stability. Besides, it has been 
reported that after endosomal uptake of nanomaterials, 
conjugated or non-specifically bound proteins degrades 
rapidly by a low-specific protease Cathepsin L, leading 
to significant loss of function of bio-conjugated particles. 
In particular, for nanomaterials that were encompass-
ing intracellular targeting molecules or pharmaceutical 
active drugs such effects can have noteworthy conse-
quences. Likewise, mostly biologically relevant moieties 
will be degraded more easily; the nanomaterials can be 
stripped from their surface corona resulting in differ-
ent physicochemical properties such as intra-endosomal 
aggregation [87–89].
On the contrary, proteins bind to the nanoparticles in 
biological fluids leading to generating surface coating on 
a nanomaterial known as the protein corona. This pro-
tein corona considerably affects the interaction of the 
nanomaterials with biological systems. In highly dynamic 
physiological systems it is imperative to understand the 
formation and development of protein-corona and its 
biological relevancy prior to employing such materials 
for biomedical applications. In this viewpoint, by using 
silica and polystyrene nanoparticles of various size and 
surface functionalization in human plasma, corona for-
mation has been studied. This study has revealed rapid 
material-specific corona formation of almost 300 differ-
ent proteins. Furthermore, it has been established that 
though the composition of specific corona did not differ 
considerably over the time but the amount of bound pro-
tein changed significantly. The properties of the biomol-
ecules derived surface corona can be directly linked to 
its biological impacts. Therefore, critical assessment and 
basic knowledge of such nano-bio interfacial interactions 
became imperative in terms of rates, affinities and stoi-
chiometries of protein association with, and dissociation 
from respective nanomaterial. Proteins associated on the 
surface of a nanomaterial, amount and arrangement of 
the proteins on the surface can play a central role in an 
in vivo response [90]. It has already been established that 
the rapid corona formation affects haemolysis, thrombo-
cyte activation, nanomaterial uptake and endothelial cell 
death at an early exposure [91–93]. Interestingly, amend-
ment in secondary structure of protein and consequent 
changes in its activity upon binding to nanomaterials 
surface may have disadvantage and it may be a potential 
source of nanotoxicity. However, such functional nano-
materials can be utilized towards promising applications 
of nanoparticles in increasing protein stability toward 
enzyme degradation and increasing enzymes activity 
via immobilization at surfaces [94]. From the above dis-
cussion, it is apparent that alongside aggregation and 
stability, formation of protein corona is an imperative 
physicochemical property need to be considered care-
fully due to its influential role at nano-bio interface.
2.4  Surface functionalization/chemistry and exterior 
corona
In order to retain biomedical potential of nanomaterials, 
it is vital to control their aggregation characteristic and 
develop specific chemistry or surface corona on nano-
materials exterior, which can be achieved by their surface 
coatings or functionalization. In addition to controlling 
aggregation, tailored surface corona or functionaliza-
tion of nanomaterials may generate different interesting 
opportunities to develop efficient nano-agents in highly 
controlled fashion for biomedical applications [25, 26]. 
In this context, design and development of surface-mod-
ification schemes for silica nanoparticles have been sug-
gested wherein an optimum balance of inert and active 
surface functional groups was strategically attained to 
reduce particle aggregation and their nonspecific bind-
ing. Where, silica nanoparticles were primed in a water-
in-oil microemulsion followed by co-hydrolysis with 
tetraethyl orthosilicate (TEOS) and different organosi-
lane reagents in order to develop various surface modi-
fications. Moreover, it has been demonstrated that by 
employing suitable surface-modification stratagem, 
fluorescent dye-doped silica nanoparticles can be read-
ily conjugated with biological molecules for DNA chip 
or other type of bio-analytical applications as sensitive, 
reproducible and fluorescent labels [95]. Likewise, other 
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nanomaterials such as magnetic iron oxide nanoparticles, 
zinc oxide, carbon nanotubes, gold nanoparticles, silver 
nanoparticles and many more can be functionalized by 
small molecule ligands, polymers and biomolecules [9, 
18, 25, 26, 96–98].
Recently, a new synthetic scheme has been established 
wherein gold and silver nanoparticles were surface func-
tionalized by creating stable surface corona of biologi-
cally-active polyoxometalates (POMs) and precise surface 
chemistry [25, 26]. This functionalization was accom-
plished by employing zwitterionic amino acid tyrosine as 
a pH-switchable reducing and capping agent around sil-
ver nanoparticles. Furthermore, significant improvement 
in antibacterial profile of both gold and silver nanoparti-
cles was reported due to enhancement in degree of physi-
cal destruction, as illustrated for silver nanoparticles in 
Fig. 4a–d [25, 26]. Interestingly, reported silver nanopar-
ticles exhibited significant antibacterial potential toward 
both tested Gram negative and positive bacterial strains 
with similar toxicity pattern. Nevertheless, further inves-
tigation on PC-3 epithelial cells revealed that these func-
tionalized silver nanoparticles do not have any significant 
cytotoxicity or physical damage toward mammalian cells 
as shown in Fig. 4e–h. Although, authors could not pro-
vide full explanation for the discriminating toxicity of 
silver nanoparticles towards the tested Gram bacterial 
strains and PC-3 epithelial cells however, with reference 
to Clement and Jarrett [99] report it was established that 
the toxicity of silver to human cells is substantially lower 
than to bacteria. Moreover, most widely documented 
usages of silver are prophylactic treatment of burns and 
water disinfection. Alike outcomes have been confirmed 
with the biosynthesized silver nanoparticles, which dis-
played admirable antibacterial efficacy toward both Gram 
positive and negative bacteria but exposed good cyto-
compatibility with mammalian cells [100]. Furthermore, 
in  vitro toxicity of silver nanoparticles at non-cytotoxic 
doses has been evaluated in human hepatoma cell line 
and HepG2 by various assays, wherein it was revealed 
that silver nanoparticles accelerate cell proliferation at 
low doses (<0.5 mg/L) due to stimulation of genes associ-
ated with cell cycle progression. Contrariwise, notewor-
thy cytotoxicity at higher doses (>1.0 mg/L) was reported 
due to abundant abnormal morphological changes. 
Further, in this study it was established that both silver 
nanoparticles and leaching of Ag+ ions from nanoparticle 
contribute to the toxic effects [101]. Therefore, thorough 
understanding of leaching behaviour of Ag+ ions from 
particle, their kinetics and toxicity of silver nanoparticles 
yet need to be established in the context of their underly-
ing medical debate for the safe use of silver based materi-
als. Nevertheless, based on the available knowledge it can 
be proposed that such engineered nanomaterials can be 
used for specific antimicrobial targeting without any con-
siderable damage to mammalian cells at lower concentra-
tions [25].
Furthermore, sequential surface functionalization 
approach was verified in the case of gold nanoparticles by 
using cationic amino acid lysine in the outermost shell as 
exemplified in Fig. 5, to assist these gold nanomaterials in 
directing toward negatively charged bacterial cells. This 
research revealed that gold nanoparticles, which are con-
sidered highly biocompatible in nature, can be regulated 
to be a strong antimicrobial agent by fine-tuning their 
surface functionalization in a controllable manner [26]. 
These investigations recommend that facile tailorability 
of nanomaterials surfaces may play a substantial role in 
controlling their biological activities.
From the above discussion, it is clear that tuneable sur-
face functionalities of various nanomaterials provide ver-
satile scaffolds for a variety of biomedical applications. 
For example, appropriate control of surface properties 
Fig. 4 SEM micrographs of E. coli and phase contrast micrographs of human PC3 epithelial cells (a, e) before and (b–d, f–h) after treatment with 
AgNPsTyr, AgNPsTyr@PTA and AgNPsTyr@PMA, respectively (adopted from Ref. [34])
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can exploit therapeutic efficacy whereas it can reduce 
hostile side effects. In addition to this, attentive choice 
of nanomaterial functionalization/coating can decrease 
the adverse influence on the environment [102]. How-
ever, several essential features of nanomaterials surface 
functionalization need to be addressed during translation 
from experimental triumph to clinical preparation. For 
rational design of nanomaterials, surface modifications 
should be fabricated to provide biomimetic properties 
like stability in complex biological media, non-cytotox-
icity and specificity toward a particular biological entity. 
Such acquaintance of nanomaterials surface func-
tionalization dependent biological activities may have 
impact on designing effective therapeutic nanomaterials 
for diagnosis and treatment of diseases [98]. From the 
above discussion, it can be highlighted that the nano-
material toxicity and biological applicability are strongly 
governed by their surface functionalization and exterior 
corona, which need to be engineered with extreme care-
fulness for any biomedical application for specificity and 
non-cytotoxicity.
2.5  Surface charge
Alongside surface corona and surface chemistry, surface 
charge is a distinguishing physicochemical property of a 
nanomaterial. Surface charge of a particular nanomaterial 
has potential to govern its biomedical and toxicological 
actions and it is critical for providing insight of nano-bio 
interaction under different experimental set-ups. In addi-
tion to ionic strength and solution pH, surface charge 
has significant influence for the progress of aggregation 
in aqueous milieu. Furthermore, it plays fundamental 
role in governing initial electrostatic interaction at nano-
bio interface and positive surface charged nanomateri-
als have been reported for toxicity on living organisms. 
Peripheral surface layers can convey selective charge on 
nanomaterials providing them stability as discussed ear-
lier while guiding their surface chemistry. Moreover, the 
cellular entry of a nanomaterial definitely depends on 
its surface charge and toxic effects of positively charged 
nanomaterial have widely been explored, but it was not 
observed when the same material coated with negatively 
charged functional groups [103, 104].
It has also been reported that nanomaterials with cati-
onic surface charge are more likely to intermingle with 
the genetic material triggering genotoxicity due to nega-
tive charge on DNA. On contrary, if surface charge on a 
nanomaterial is alike charge of the cell membranes, this 
may induce repulsion and prevent nanomaterial-cell con-
tact. In general, cell membranes possess negative charge, 
therefore, it is believed that nanomaterials with negative 
surface charge may internalize slower compared to their 
Fig. 5 Schematic representation of tyrosine-mediated synthesis of gold nanoparticles, followed by their sequential surface functionalization with 
PTA or PMA and lysine (adopted from Ref. [33])
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positively surface charged counterparts. Furthermore, 
contemporary research suggest that positive surface 
charge bearing nanomaterials are primarily being inter-
nalized through clathrin-mediated endocytosis (CME) 
including chitosan, PLGA modified with PLL, amino 
group-modified SNTs etc. However, some exception have 
been documented wherein multiple pathways including 
caveolae-mediated endocytosis were observed for inter-
nalization of strong cationic surface charged nanomateri-
als [105]. The impact of surface charge on cellular uptake 
and in vitro cytotoxicity of mesoporous silica nanoparti-
cles in human mesenchymal stem cells (hMSCs) has been 
evaluated; wherein, it was revealed that the mesoporous 
silica nanoparticles uptake by hMSCs can be regulated 
by a threshold of positive surface charge. In addition to 
this, further it was proposed that the inflection of surface 
charge on mesoporous silica nanoparticles uptake is spe-
cific to cell type [106].
Moreover, critical role of surface charge of gold nano-
particles in modulating membrane potential of differ-
ent malignant and non-malignant cell types followed by 
their downstream intracellular events was established 
in recent times; which revealed a novel mechanism for 
cell-nanoparticle interactions and gold nanoparticles 
uptake. Positively charged gold nanoparticles were taken-
up intracellularly based on the membrane potential and 
generate membrane depolarization. This action improved 
[Ca2+]intracellular by increasing Ca2+ influx and inducing 
release of intracellular Ca2+ stores via endoplasmic retic-
ulum through IP3 receptor channels. All these variations 
can result in higher apoptosis and lower cell proliferation, 
subjected to cell type. Added modulation of cell apop-
tosis and proliferation may involve direct nanoparticle 
effects on intracellular signalling mechanisms [107]. All 
such studies with reference to surface charge of various 
nanomaterials are expected to help in developing under-
standing of various biological events of cell-nanoparticle 
contacts, which will support in expedite the engineer-
ing of nanoparticles for specific intracellular targets for 
therapeutic applications with controlled toxicological 
perspectives.
2.6  External and neglected properties
In addition to various inherent physicochemical char-
acteristics as discussed in previous sections, external 
influences may also have noteworthy consequence on 
biomedical or toxicological belongings of nanomateri-
als. For example, in the presence of light, photosensi-
tive nanomaterials will be capable of producing higher 
amount of reactive oxygen species (ROS) which will have 
considerable toxicological effects. In this context, three 
photosensitive nanomaterials, titanium dioxide, silicon 
dioxide and zinc oxide have been assessed to possess 
toxicity with varying degrees toward Gram positive and 
Gram negative bacterial strains in water suspensions by 
particle concentration dependent manner. This research 
claims that the stimulus of light had significant influence 
under most of the examined experimental conditions 
which is possibly related with its role in motivating pro-
duction of ROS [108].
Furthermore, purity of any nanomaterial is one of the 
most important characteristic, which need to be consid-
ered for its biomedical or toxicological role. However, it 
has often been neglected, which needs to be considered 
for its active role in therapeutics or otherwise. Existence 
of residual contaminating foreign metals, unreduced 
metal ions, chemicals or other agents (from the precursor 
material used for nanomaterials synthesis) may actually 
be responsible for noxious actions rather than the actual 
nanomaterials itself and the quantity of contaminating 
materials are fully dependent upon the synthesis method 
used. Currently, numerous post-production nanoma-
terials processing methods are known to remove most 
of these precursor metal catalysts and chemical agents 
from nanomaterials; however, such purified nanomateri-
als may still have some amount of remaining substances. 
Therefore, the effects of such chemical impurities, resid-
ual metals and presence of counter ions on both potential 
biomedical and deleterious effects cannot be overlooked. 
Hydrophobicity/hydrophilicity, electron transfer capabil-
ity, surface smoothness/roughness/defects, oxidizability 
of nanomaterials in physiological conditions and counter 
ion effects are other essential physicochemical param-
eters of diverse nano objects that need to be considered 
to control their toxic potential while engineering nano-
materials for their biomedical applications. For instance, 
one of the recent studies used multiparametric method-
ology to understand high-content imaging coupled with 
gene expression analysis on fundamental pathways for 
evaluating cell-nanomaterial interactions. By employing 
this approach the effect of the surface charge and hydro-
phobicity of gold nanoparticles on cell-material interac-
tions were parametrically evaluated followed by their 
validation through biochemical assays. Interestingly, the 
data evidently divulge that while surface hydrophobicity 
of nanomaterial does not essentially affect cellular uptake 
levels, nevertheless increased surface hydrophobicity was 
found to be associated with higher cell membrane dam-
age and induction of autophagy, which had greater influ-
ence than the effect of surface charge ranging between 
−50 and +20 mV [109]. In another study, it has been con-
firmed that hydrophobic and hydrophilic graphene can 
differentially influence nano-bio interactions and their 
toxicity profile. Comparison between, highly hydropho-
bic pristine graphene and carboxyl functionalized hydro-
philic graphene with monkey renal cells have revealed 
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large accumulation of hydrophobic graphene on the cell 
membrane inducing intracellular reactive oxygen species 
(ROS) stress leading to apoptosis, whereas functionalized 
hydrophilic graphene was internalized by the cells with-
out causing any toxicity. These results were evident from 
confocal microscopy and cell function assays confirming 
significant importance of surface pacification to control 
strong hydrophobic interaction associated with toxicity 
effects of graphene through carboxyl functionalization. 
However, it is imperative to state that graphene is a non-
biodegradable material with higher cellular internaliza-
tion capacity. Therefore, the potential long-term hostile 
effects of functionalized hydrophilic graphene need to 
be explored yet to realize their full biomedical capabili-
ties [110]. From the discussion, it can be clinched that the 
controlled experimental conditions and suitable func-
tionalization may provide comparability across studies. 
This is imperative for reliable illustration of nanomaterial 
structure–activity correlations, which is prerequisite for 
the potential application of nanoparticles in medicine.
3  Conclusion
Nanotechnology has significant potential to influence 
field of biology and medicine due to nanoscale size of 
basic biological entities and it is gaining considerable 
attention in terms of nanomedicine. However, toxico-
logical perspectives of engineered nanomaterials are 
poorly understood or rather unclear, which is limiting full 
potential of nanomedicine. Therefore, the often ignored 
toxicological concerns of engineered nanomaterials need 
urgent attention and it is essential to carry out fundamen-
tal research to address these issues. Moreover, the future 
of nanomedicine will depend on rational engineering of 
various nanomaterials with controlled physicochemi-
cal properties to dictate their interactions in anticipated 
manner with biological systems for biomedical applica-
tions. Additionally, detailed and thorough understand-
ing of nano-bio interactions will be required to discover 
favourable physicochemical characteristics of various 
nanomaterials, which may render them more responsive 
toward inner biological environment for therapeutic ben-
efits without any toxic impact.
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